The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Anti-aging drugs are used to slow down or reverse the processes of aging to extend the lifespan. Aging, is that damage to the body’s macromolecules, cells, tissues, which is facilitated by genomic instability, epigenetic alterations, loss of proteostasis, mitochondrial dysfunction, cellular senescence, stem cell exhaustion, oxidation damage by free radicals etc
The global Anti-Ageing Drugs market size is expected to reach US$ 140690 million by 2029, growing at a CAGR of 7.5% from 2023 to 2029. The market is mainly driven by the significant applications of Anti-Ageing Drugs in various end use industries. The expanding demands from the Skin, Hair and Others,, are propelling Anti-Ageing Drugs market. Hormonal Therapy, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Antioxidants segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Anti-Ageing Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Anti-Ageing Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Anti-Ageing Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Anti-Ageing Drugs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Anti-Ageing Drugs covered in this report include Nu Skin, BIOTIME, Elysium Health, La Roche-Posay and DermaFix, etc.
The global Anti-Ageing Drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
- Nu Skin
- BIOTIME
- Elysium Health
- La Roche-Posay
- DermaFix
Global Anti-Ageing Drugs market, by region:
- North America (U.S., Canada, Mexico)
- Europe (Germany, France, UK, Italy, etc.)
- Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
- South America (Brazil, etc.)
- Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Anti-Ageing Drugs market, Segment by Type:
- Hormonal Therapy
- Antioxidants
- Enzymes
- Stem Cells
- Others
Global Anti-Ageing Drugs market, by Application
- Skin
- Hair
- Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Anti-Ageing Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Anti-Ageing Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Anti-Ageing Drugs Market Overview
1.1 Anti-Ageing Drugs Product Overview
1.2 Anti-Ageing Drugs Market Segment by Type
1.2.1 Hormonal Therapy
1.2.2 Antioxidants
1.2.3 Enzymes
1.2.4 Stem Cells
1.2.5 Others
1.3 Global Anti-Ageing Drugs Market Size by Type
1.3.1 Global Anti-Ageing Drugs Market Size Overview by Type (2018-2029)
1.3.2 Global Anti-Ageing Drugs Historic Market Size Review by Type (2018-2023)
1.3.3 Global Anti-Ageing Drugs Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Anti-Ageing Drugs Sales Breakdown by Type (2018-2023)
1.4.2 Europe Anti-Ageing Drugs Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Anti-Ageing Drugs Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Anti-Ageing Drugs Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Anti-Ageing Drugs Sales Breakdown by Type (2018-2023)
2 Global Anti-Ageing Drugs Market Competition by Company
2.1 Global Top Players by Anti-Ageing Drugs Sales (2018-2023)
2.2 Global Top Players by Anti-Ageing Drugs Revenue (2018-2023)
2.3 Global Top Players by Anti-Ageing Drugs Price (2018-2023)
2.4 Global Top Manufacturers Anti-Ageing Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Anti-Ageing Drugs Market Competitive Situation and Trends
2.5.1 Anti-Ageing Drugs Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Anti-Ageing Drugs Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anti-Ageing Drugs as of 2022)
2.7 Date of Key Manufacturers Enter into Anti-Ageing Drugs Market
2.8 Key Manufacturers Anti-Ageing Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Anti-Ageing Drugs Status and Outlook by Region
3.1 Global Anti-Ageing Drugs Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Anti-Ageing Drugs Historic Market Size by Region
3.2.1 Global Anti-Ageing Drugs Sales in Volume by Region (2018-2023)
3.2.2 Global Anti-Ageing Drugs Sales in Value by Region (2018-2023)
3.2.3 Global Anti-Ageing Drugs Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Anti-Ageing Drugs Forecasted Market Size by Region
3.3.1 Global Anti-Ageing Drugs Sales in Volume by Region (2024-2029)
3.3.2 Global Anti-Ageing Drugs Sales in Value by Region (2024-2029)
3.3.3 Global Anti-Ageing Drugs Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Anti-Ageing Drugs by Application
4.1 Anti-Ageing Drugs Market Segment by Application
4.1.1 Skin
4.1.2 Hair
4.1.3 Others
4.2 Global Anti-Ageing Drugs Market Size by Application
4.2.1 Global Anti-Ageing Drugs Market Size Overview by Application (2018-2029)
4.2.2 Global Anti-Ageing Drugs Historic Market Size Review by Application (2018-2023)
4.2.3 Global Anti-Ageing Drugs Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Anti-Ageing Drugs Sales Breakdown by Application (2018-2023)
4.3.2 Europe Anti-Ageing Drugs Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Anti-Ageing Drugs Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Anti-Ageing Drugs Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Anti-Ageing Drugs Sales Breakdown by Application (2018-2023)
5 North America Anti-Ageing Drugs by Country
5.1 North America Anti-Ageing Drugs Historic Market Size by Country
5.1.1 North America Anti-Ageing Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Anti-Ageing Drugs Sales in Volume by Country (2018-2023)
5.1.3 North America Anti-Ageing Drugs Sales in Value by Country (2018-2023)
5.2 North America Anti-Ageing Drugs Forecasted Market Size by Country
5.2.1 North America Anti-Ageing Drugs Sales in Volume by Country (2024-2029)
5.2.2 North America Anti-Ageing Drugs Sales in Value by Country (2024-2029)
6 Europe Anti-Ageing Drugs by Country
6.1 Europe Anti-Ageing Drugs Historic Market Size by Country
6.1.1 Europe Anti-Ageing Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Anti-Ageing Drugs Sales in Volume by Country (2018-2023)
6.1.3 Europe Anti-Ageing Drugs Sales in Value by Country (2018-2023)
6.2 Europe Anti-Ageing Drugs Forecasted Market Size by Country
6.2.1 Europe Anti-Ageing Drugs Sales in Volume by Country (2024-2029)
6.2.2 Europe Anti-Ageing Drugs Sales in Value by Country (2024-2029)
7 Asia-Pacific Anti-Ageing Drugs by Region
7.1 Asia-Pacific Anti-Ageing Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Anti-Ageing Drugs Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Anti-Ageing Drugs Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Anti-Ageing Drugs Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Anti-Ageing Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Anti-Ageing Drugs Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Anti-Ageing Drugs Sales in Value by Region (2024-2029)
8 Latin America Anti-Ageing Drugs by Country
8.1 Latin America Anti-Ageing Drugs Historic Market Size by Country
8.1.1 Latin America Anti-Ageing Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Anti-Ageing Drugs Sales in Volume by Country (2018-2023)
8.1.3 Latin America Anti-Ageing Drugs Sales in Value by Country (2018-2023)
8.2 Latin America Anti-Ageing Drugs Forecasted Market Size by Country
8.2.1 Latin America Anti-Ageing Drugs Sales in Volume by Country (2024-2029)
8.2.2 Latin America Anti-Ageing Drugs Sales in Value by Country (2024-2029)
9 Middle East and Africa Anti-Ageing Drugs by Country
9.1 Middle East and Africa Anti-Ageing Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Anti-Ageing Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Anti-Ageing Drugs Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Anti-Ageing Drugs Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Anti-Ageing Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Anti-Ageing Drugs Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Anti-Ageing Drugs Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Nu Skin
10.1.1 Nu Skin Company Information
10.1.2 Nu Skin Introduction and Business Overview
10.1.3 Nu Skin Anti-Ageing Drugs Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Nu Skin Anti-Ageing Drugs Products Offered
10.1.5 Nu Skin Recent Development
10.2 BIOTIME
10.2.1 BIOTIME Company Information
10.2.2 BIOTIME Introduction and Business Overview
10.2.3 BIOTIME Anti-Ageing Drugs Sales, Revenue and Gross Margin (2018-2023)
10.2.4 BIOTIME Anti-Ageing Drugs Products Offered
10.2.5 BIOTIME Recent Development
10.3 Elysium Health
10.3.1 Elysium Health Company Information
10.3.2 Elysium Health Introduction and Business Overview
10.3.3 Elysium Health Anti-Ageing Drugs Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Elysium Health Anti-Ageing Drugs Products Offered
10.3.5 Elysium Health Recent Development
10.4 La Roche-Posay
10.4.1 La Roche-Posay Company Information
10.4.2 La Roche-Posay Introduction and Business Overview
10.4.3 La Roche-Posay Anti-Ageing Drugs Sales, Revenue and Gross Margin (2018-2023)
10.4.4 La Roche-Posay Anti-Ageing Drugs Products Offered
10.4.5 La Roche-Posay Recent Development
10.5 DermaFix
10.5.1 DermaFix Company Information
10.5.2 DermaFix Introduction and Business Overview
10.5.3 DermaFix Anti-Ageing Drugs Sales, Revenue and Gross Margin (2018-2023)
10.5.4 DermaFix Anti-Ageing Drugs Products Offered
10.5.5 DermaFix Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Anti-Ageing Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Anti-Ageing Drugs Industrial Chain Analysis
11.4 Anti-Ageing Drugs Market Dynamics
11.4.1 Anti-Ageing Drugs Industry Trends
11.4.2 Anti-Ageing Drugs Market Drivers
11.4.3 Anti-Ageing Drugs Market Challenges
11.4.4 Anti-Ageing Drugs Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Anti-Ageing Drugs Distributors
12.3 Anti-Ageing Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
